Relationship between serum TGF-β1, sST2 levels and lesion length and lesion degree of thoracic aortic aneurysm

Home > Archive>Volume 30, Issue 1, 2022 >54-58

Relationship between serum TGF-β1, sST2 levels and lesion length and lesion degree of thoracic aortic aneurysm
DOI:
                        
                    
CSTR:
                        
                    
Author:
                        CHANG WeiCHANG Wei
West China Guangan Affiliated Hospital of Sichuan University, Guangan, Sichuan 638000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
FENG YongjianFENG Yongjian
West China Guangan Affiliated Hospital of Sichuan University, Guangan, Sichuan 638000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
WANG YoulanWANG Youlan
West China Guangan Affiliated Hospital of Sichuan University, Guangan, Sichuan 638000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:West China Guang'an Affiliated Hospital of Sichuan University, Guang'an, Sichuan 638000, China)
Clc Number:R5
Fund Project:

Article

Figures

Metrics

Reference [24]

Cited by

Materials

Comments

Abstract:

Aim To investigate the relationship between serum transforming growth factor β1 (TGF-β1), soluble suppression of tumorigenicity-2 (sST2) and the length and severity of thoracic aortic aneurysm (TAA), and to analyze the diagnostic value of serum TGF-β1 and sST2 in the diagnosis of TAA. Methods A total of 72 TAA patients (TAA group) admitted to West China Guang'an Affiliated Hospital of Sichuan University from July 2018 to December 2020 and 77 healthy volunteers (control group) were selected. Serum levels of TGF-β1, sST2, inflammatory factors and fibrosis indexes were detected. The lesion length and lesion degree of TAA were measured by echocardiography. Pearson or Spearman correlation coefficient was used to describe the correlation between TGF-β1, sST2 and lesion length, lesion degree, inflammatory factors, fibrosis indexes. Logistic regression was used to analyze the risk factors of TAA and the value of TGF-β1 and sST2 in the diagnosis of TAA was analyzed by receiver operating characteristic (ROC) curve. ResultsThe levels of serum TGF-β1 and sST2 were higher in TAA group than those in control group (t＝18.0,7.534, P＜0.05). Serum TGF-β1 and sST2 levels were positively correlated with the length of thoracic aortic lesion, the degree of thoracic aortic lesion, interleukin-1β(IL-1β), interleukin-6(IL-6), interleukin-33(IL-33), hyaluronic acid(HA), type Ⅲ procollagen(PCⅢ), type Ⅳ collagen, Ⅳ-C), and laminin(LN) (r/r_s＝0.751～0.921, P＜0.05). High levels of IL-33 (OR(95%CI)＝1.250(1.062～1.471)), PCⅢ(OR (95%CI)＝1.390(1.131～1.707)), Ⅳ-C(OR(95%CI)＝1.141(1.005～1.296)), TGF-β1(OR(95%CI)＝2.447 (1.370～4.372)) and sST2 (OR(95%CI)＝1.749 (1.327～2.306)) were risk factors for TAA (P＜0.05). The area under curve (AUC) of combined TGF-β1 and sST2 for diagnosis of TAA was 0.826, which was higher than that of TGF-β1 and sST2 alone (P＜0.05). Conclusion The increase of serum TGF-β1 and sST2 levels is associated with the occurrence of TAA, the length and degree of TAA lesion, and can be used as a potential indicator for the evaluation of TAA disease.

Key words:transforming growth factor; soluble suppression of tumorigenicity-2; thoracic aortic aneurysm; inflammatory response; fibrosis

Reference

[1] MILEWICZ D M, RAMIREZ F.Therapies for thoracic aortic aneurysms and acute aortic dissections.Arterioscler Thromb Vasc Biol, 9,9(2):126-136.

[2] TAKADA M, YAMAGISHI K, TAMAKOSHI A, et al.Body mass index and mortality from aortic aneurysm and dissection.J Atheroscler Thromb, 1,8(4):338-348.

[3] 段卡丹, 张守彦, 李松森, 等.MAPK信号通路在转化生长因子β1诱导心肌成纤维细胞趋化运动中的作用.中国动脉硬化杂志, 0,8(11):966-971.

[4] CHEN Y T, JHAO P Y, HUNG C T, et al.Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts.J Clin Invest, 1,1(5):143645.

[5] AIMO A, JANUZZI J J, BAYES-GENIS A, et al.Clinical and prognostic significance of sST2 in heart failure:JACC review topic of the week.J Am Coll Cardiol, 9,4(17):2193-2203.

[6] 赵小龙, 陈文亮.IL-33/ST2信号通路在急性胰腺炎及纤维化中的作用.中国现代普通外科进展, 9,2(2):121-125.

[7] ERBEL R, ABOYANS V, BOILEAU C, et al.2014 ESC guidelines on the diagnosis and treatment of aortic diseases.Kardiol Pol, 4,2(12):1169-1252.

[8] 吴祁红, 吕安康, 陈颖, 等.血清EREG和MGP水平与胸主动脉瘤的关系.国际心血管病杂志, 2,9(4):248-250.

[9] SAEYELDIN A A, VELASQUEZ C A, MAHMOOD S, et al.Thoracic aortic aneurysm:unlocking the “silent killer” secrets.Gen Thorac Cardiovasc Surg, 9,7(1):1-11.

[10] BALMFORTH D, HARKY A, ADAMS B, et al.Is there a role for biomarkers in thoracic aortic aneurysm disease?.Gen Thorac Cardiovasc Surg, 9,7(1):12-19.

[11] SCHAFER S, VISWANATHAN S, WIDJAJA A A, et al.IL-11 is a crucial determinant of cardiovascular fibrosis.Nature, 7,2(7683):110-115.

[12] ELIAS M, ZHAO S, LE H T, et al.IL-36 in chronic inflammation and fibrosis-bridging the gap?.J Clin Invest, 1,1(2):144336.

[13] GOUMANS M J, TEN DIJKE P.TGF-β signaling in control of cardiovascular function.Cold Spring Harb Perspect Biol, 8,0(2):a022210.

[14] GHAFOORY S, VARSHNEY R, ROBISON T, et al.Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury.Blood Adv, 8,2(5):470-480.

[15] LU M, QIN Q, YAO J, et al.Induction of LOX by TGF-β1/Smad/AP-1 signaling aggravates rat myocardial fibrosis and heart failure.IUBMB Life, 9,1(11):1729-1739.

[16] CAI X, LI Y, FU S, et al.LncRNA AK131850 is downregulated in thoracic aortic aneurysm and negatively affects the levels of TGF-β1 in aortic smooth muscle cells.Arch Physiol Biochem, 2020.DOI:10.1080/13813455.2020.1767653.

[17] FORTE A, GALDERISI U, CIPOLLARO M, et al.Epigenetic regulation of TGF-β1 signalling in dilative aortopathy of the thoracic ascending aorta.Clin Sci (Lond), 6,0(16):1389-1405.

[18] 林绍慧, 盛净, 马绍骏, 等.CTRP3对TGF-β1麟诱导的血管外膜成纤维细胞增殖及α-SMA表达的影响.上海交通大学学报(医学版), 4,4(3):274-278.

[19] HABASHI J P, JUDGE D P, HOLM T M, et al.Losartan,an AT1 antagonist,prevents aortic aneurysm in a mouse model of Marfan syndrome.Science, 6,2(5770):117-121.

[20] TYMIN＇SKA A, KAPON-CIELICKA A, OZIERAN＇SKI K, et al.Association of galectin-3 and soluble ST2 with in-hospital and one-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary.Pol Arch Intern Med, 9,9(11):770-780.

[21] YANG Y, LIU H, ZHANG H, et al.ST2/IL-33-Dependent microglial response limits acute ischemic brain injury.J Neurosci, 7,7(18):4692-4704.

[22] AMBARI A M, SETIANTO B, SANTOSO A, et al.Angiotensin converting enzyme inhibitors (ACEIs) decrease the progression of cardiac fibrosis in rheumatic heart disease through the inhibition of IL-33/sST2.Front Cardiovasc Med, 0,7:115.

[23] 马红利, 彭瑜, 李超, 等.sST2参与急性心肌梗死后心肌纤维化.中国动脉硬化杂志, 7,5(7):715-718.

[24] AIMO A, VERGARO G, RIPOLI A, et al.Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure.JACC Heart Fail, 7,5(4):287-296.

Get Citation

CHANG Wei, FENG Yongjian, WANG Youlan. Relationship between serum TGF-β1, sST2 levels and lesion length and lesion degree of thoracic aortic aneurysm[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(1):54-58.

Copy

Article Metrics

Abstract:503
PDF: 636
HTML: 0
Cited by: 0

History

Received:July 11,2021
Revised:September 21,2021
Adopted:
Online: January 07,2022
Published:

Policies & Instructions

Get Citation

Share

Article Metrics

History

Article QR Code